Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm

Background: Percutaneous ethanol injection has been successfully used for hepatocelular carcinomas (HCC) smaller than 5 cm in size. For larger lesions large volume ethanol injection has not been well explored. Aim: Evaluate the results of intraoperative Ultrasonographic-guided large volume ethanol i...

Full description

Bibliographic Details
Main Authors: Ricardo Mondragón-Sánchez, Ana Lilia Garduño-López, Elvira Gómez-Gómez, Mauricio Frias-Mendivil, Alejandro Mondragón-Sánchez, Rigoberto Bernal-Maldonado
Format: Article
Language:English
Published: Elsevier 2005-07-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119320666
_version_ 1819108164095705088
author Ricardo Mondragón-Sánchez
Ana Lilia Garduño-López
Elvira Gómez-Gómez
Mauricio Frias-Mendivil
Alejandro Mondragón-Sánchez
Rigoberto Bernal-Maldonado
author_facet Ricardo Mondragón-Sánchez
Ana Lilia Garduño-López
Elvira Gómez-Gómez
Mauricio Frias-Mendivil
Alejandro Mondragón-Sánchez
Rigoberto Bernal-Maldonado
author_sort Ricardo Mondragón-Sánchez
collection DOAJ
description Background: Percutaneous ethanol injection has been successfully used for hepatocelular carcinomas (HCC) smaller than 5 cm in size. For larger lesions large volume ethanol injection has not been well explored. Aim: Evaluate the results of intraoperative Ultrasonographic-guided large volume ethanol injection for HCC larger than 4 cm in size. Patients and methods: Ten patients were candidates for this treatment between June 1999 and July 2003. A retrospective review of the clinical files was performed. Absolute ethanol, average of 100 mL (range 80-120 mL) was administered intraoperatively. Follow-up evaluation included alpha-fetoprotein (AFP) and ultrasound or computed tomography. Results: There were six women and four men, the median age was 62 years (range 56-80). The median lesion size was 8 cm (range 4-15 cm). Hepatitis C liver cirrhosis was the most common associated chronic liver disease (70%). A significant reduction of AFP levels after treatment was observed (Initial 966 ng/dL, post treatment levels: 42 ng/dL) US and CT scan showed tumor necrosis. Morbidity was 40%. No operative mortality was recorded. The one and four year survival rate was 60% and 20%. Conclusion: Intraoperative US-guided large volume ethanol injection is a safe palliative therapy for cirrhotic patients with HCC lesions greater than 5 cm in size. The impact on survival should be compared in a controlled double blind study.
first_indexed 2024-12-22T03:05:34Z
format Article
id doaj.art-c47f487181174e4ab1969595c0ea9cc6
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-12-22T03:05:34Z
publishDate 2005-07-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-c47f487181174e4ab1969595c0ea9cc62022-12-21T18:41:04ZengElsevierAnnals of Hepatology1665-26812005-07-0143200203Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cmRicardo Mondragón-Sánchez0Ana Lilia Garduño-López1Elvira Gómez-Gómez2Mauricio Frias-Mendivil3Alejandro Mondragón-Sánchez4Rigoberto Bernal-Maldonado5Departments of Gastroenterology; Instituto Nacional de Cancerología, Mexico City. Division of Surgery. Centro Médico ISSEMyM, Metepec, México; Address for correspondence:Departments of GastroenterologyDepartments of GastroenterologyDepartments of EpidemiologyInstituto Nacional de Cancerología, Mexico City. Division of Surgery. Centro Médico ISSEMyM, Metepec, MéxicoDepartments of GastroenterologyBackground: Percutaneous ethanol injection has been successfully used for hepatocelular carcinomas (HCC) smaller than 5 cm in size. For larger lesions large volume ethanol injection has not been well explored. Aim: Evaluate the results of intraoperative Ultrasonographic-guided large volume ethanol injection for HCC larger than 4 cm in size. Patients and methods: Ten patients were candidates for this treatment between June 1999 and July 2003. A retrospective review of the clinical files was performed. Absolute ethanol, average of 100 mL (range 80-120 mL) was administered intraoperatively. Follow-up evaluation included alpha-fetoprotein (AFP) and ultrasound or computed tomography. Results: There were six women and four men, the median age was 62 years (range 56-80). The median lesion size was 8 cm (range 4-15 cm). Hepatitis C liver cirrhosis was the most common associated chronic liver disease (70%). A significant reduction of AFP levels after treatment was observed (Initial 966 ng/dL, post treatment levels: 42 ng/dL) US and CT scan showed tumor necrosis. Morbidity was 40%. No operative mortality was recorded. The one and four year survival rate was 60% and 20%. Conclusion: Intraoperative US-guided large volume ethanol injection is a safe palliative therapy for cirrhotic patients with HCC lesions greater than 5 cm in size. The impact on survival should be compared in a controlled double blind study.http://www.sciencedirect.com/science/article/pii/S1665268119320666Large hepatocellular carcinomapercutaneous ethanol injectionnonresectional therapies
spellingShingle Ricardo Mondragón-Sánchez
Ana Lilia Garduño-López
Elvira Gómez-Gómez
Mauricio Frias-Mendivil
Alejandro Mondragón-Sánchez
Rigoberto Bernal-Maldonado
Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm
Annals of Hepatology
Large hepatocellular carcinoma
percutaneous ethanol injection
nonresectional therapies
title Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm
title_full Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm
title_fullStr Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm
title_full_unstemmed Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm
title_short Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm
title_sort intraoperative us guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm
topic Large hepatocellular carcinoma
percutaneous ethanol injection
nonresectional therapies
url http://www.sciencedirect.com/science/article/pii/S1665268119320666
work_keys_str_mv AT ricardomondragonsanchez intraoperativeusguidedlargevolumeethanolinjectionforhepatocellularcarcinomagreaterthan4cm
AT analiliagardunolopez intraoperativeusguidedlargevolumeethanolinjectionforhepatocellularcarcinomagreaterthan4cm
AT elviragomezgomez intraoperativeusguidedlargevolumeethanolinjectionforhepatocellularcarcinomagreaterthan4cm
AT mauriciofriasmendivil intraoperativeusguidedlargevolumeethanolinjectionforhepatocellularcarcinomagreaterthan4cm
AT alejandromondragonsanchez intraoperativeusguidedlargevolumeethanolinjectionforhepatocellularcarcinomagreaterthan4cm
AT rigobertobernalmaldonado intraoperativeusguidedlargevolumeethanolinjectionforhepatocellularcarcinomagreaterthan4cm